Nanomaterials‐Mediated Co‐Stimulation of Toll‐Like Receptors and CD40 for Antitumor Immunity
Sign Up to like & getrecommendations! Published in 2022 at "Advanced Materials"
DOI: 10.1002/adma.202207486
Abstract: Toll‐like receptors (TLRs) and CD40‐related signaling pathways represent critical bridges between innate and adaptive immune responses. Here, an immunotherapy regimen that enables co‐stimulation of TLR7/8‐ and CD40‐mediated pathways is developed. TLR7/8 agonist resiquimod (R848) derived… read more here.
Keywords: toll like; immunity; stimulation; nanomaterials mediated ... See more keywords
Nanomaterials-Mediated Immunomodulation for Cancer Therapeutics
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Chemistry"
DOI: 10.3389/fchem.2021.629635
Abstract: Immunotherapy holds great promise in overcoming the limitations of conventional regimens for cancer therapeutics. There is growing interest among researchers and clinicians to develop novel immune-strategies for cancer diagnosis and treatment with better specificity and… read more here.
Keywords: nanomaterials mediated; immune system; mediated immunomodulation; cancer ... See more keywords
Nanomaterials-Mediated Therapeutics and Diagnosis Strategies for Myocardial Infarction
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Chemistry"
DOI: 10.3389/fchem.2022.943009
Abstract: The alarming mortality and morbidity rate of myocardial infarction (MI) is becoming an important impetus in the development of early diagnosis and appropriate therapeutic approaches, which are critical for saving patients’ lives and improving post-infarction… read more here.
Keywords: diagnosis; myocardial infarction; diagnosis strategies; infarction ... See more keywords